Combination Product Regulation Will Come Under Scrutiny At May 1 Meeting
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed members will have an opportunity to voice concerns over combination product regulation at a May 1 meeting with FDA Combination Products Program Director Mark Kramer